IDH1 and glioblastoma: Two recent studies on prognostic molecular markers in GBM yielded different results about EGFR. In the retrospective study by Sirui Ma et al., univariable analysis of 367 adult patients with IDH-wildtype GBM (both histological and molecular) showed that EGFR Amp was not significantly associated with OS (Ma et al., 2020).